These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7874571

  • 1. Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas.
    Elizalde PV, Guerra FK, Gravano M, Lanari C, Lippman ME, Charreau EH, Lupu R.
    Cancer Invest; 1995; 13(2):173-80. PubMed ID: 7874571
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice.
    Elizalde PV, Lanari C, Kordon E, Tezón J, Charreau EH.
    Breast Cancer Res Treat; 1990 Jul; 16(1):29-39. PubMed ID: 2145045
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of and responsiveness to transforming growth factor-beta (TGF-beta) isoforms in hormone-dependent and independent lines of mouse mammary tumors.
    Viegas MH, Salatino M, Goin M, Peters G, Labriola L, Costa da cunha J, Lanari C, Charreau EH, Elizalde PV.
    Cancer Detect Prev; 1999 Jul; 23(5):375-86. PubMed ID: 10468889
    [Abstract] [Full Text] [Related]

  • 4. [Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice].
    Elizalde PV, Balaña ME, Charreau EH.
    Medicina (B Aires); 1997 Jul; 57 Suppl 2():70-4. PubMed ID: 9580484
    [Abstract] [Full Text] [Related]

  • 5. Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines.
    Lanari C, Kordon E, Molinolo A, Pasqualini CD, Charreau EH.
    Int J Cancer; 1989 May 15; 43(5):845-50. PubMed ID: 2523869
    [Abstract] [Full Text] [Related]

  • 6. Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts.
    Gong Y, Murphy LC, Murphy LJ.
    J Steroid Biochem Mol Biol; 1994 Jul 15; 50(1-2):13-9. PubMed ID: 8049128
    [Abstract] [Full Text] [Related]

  • 7. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
    Montecchia MF, Lamb C, Molinolo AA, Luthy IA, Pazos P, Charreau E, Vanzulli S, Lanari C.
    J Steroid Biochem Mol Biol; 1999 Jan 15; 68(1-2):11-21. PubMed ID: 10215033
    [Abstract] [Full Text] [Related]

  • 8. Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate.
    Kordon E, Lanari C, Meiss R, Elizalde P, Charreau E, Dosne Pasqualini C.
    Breast Cancer Res Treat; 1990 Nov 15; 17(1):33-43. PubMed ID: 2151368
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y, Anzai Y, Murphy LC, Ballejo G, Holinka CF, Gurpide E, Murphy LJ.
    Cancer Res; 1991 Oct 15; 51(20):5476-81. PubMed ID: 1833051
    [Abstract] [Full Text] [Related]

  • 10. Estrogen inhibition of MPA-induced mouse mammary tumor transplants.
    Kordon E, Lanari C, Molinolo AA, Elizalde PV, Charreau EH, Dosne Pasqualini C.
    Int J Cancer; 1991 Dec 02; 49(6):900-5. PubMed ID: 1835715
    [Abstract] [Full Text] [Related]

  • 11. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME, Lupu R, Labriola L, Charreau EH, Elizalde PV.
    Oncogene; 1999 Nov 04; 18(46):6370-9. PubMed ID: 10597237
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production.
    Liu SC, Sanfilippo B, Perroteau I, Derynck R, Salomon DS, Kidwell WR.
    Mol Endocrinol; 1987 Oct 04; 1(10):683-92. PubMed ID: 2484711
    [Abstract] [Full Text] [Related]

  • 14. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.
    Kordon EC, Molinolo AA, Pasqualini CD, Charreau EH, Pazos P, Dran G, Lanari C.
    Breast Cancer Res Treat; 1993 Oct 04; 28(1):29-39. PubMed ID: 8123867
    [Abstract] [Full Text] [Related]

  • 15. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C, Lüthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA.
    Cancer Res; 2001 Jan 01; 61(1):293-302. PubMed ID: 11196177
    [Abstract] [Full Text] [Related]

  • 16. Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor.
    Efeyan A, Fabris V, Merani S, Lanari C, Molinolo AA.
    Breast Cancer Res Treat; 2004 Feb 01; 83(3):233-44. PubMed ID: 14758093
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV.
    Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.